About Distributed Bio
Distributed Bio is a company based in San Francisco (United States) founded in 2010 by Jacob Glanville was acquired by Charles River Laboratories in December 2020.. The company has 26 employees as of December 31, 2022. Distributed Bio offers products and services including Antibody Phage Display Services, SuperHuman and Cosmic scFV Libraries, Tungsten VHH Libraries, Tumbler Antibody Optimization Platform, and Retrogenix Off-Target Screening. Distributed Bio operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.
- Headquarter San Francisco, United States
- Employees 26 as on 31 Dec, 2022
- Founders Jacob Glanville
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Distributed Bio, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$197.34 K (USD), Grant
Aug 14, 2019
-
Investors
Charles River Laboratories
& 1 more
-
Employee Count
26
as on Dec 31, 2022
-
Acquired by
Charles River Laboratories
(Dec 31, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Distributed Bio
Distributed Bio offers a comprehensive portfolio of products and services, including Antibody Phage Display Services, SuperHuman and Cosmic scFV Libraries, Tungsten VHH Libraries, Tumbler Antibody Optimization Platform, and Retrogenix Off-Target Screening. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Services for therapeutic antibody discovery using phage libraries.
Libraries for antibody discovery and development processes.
Libraries focused on nanobody creation for therapeutics.
Platform for antibody humanization, affinity maturation, and stability.
Services for in vitro and in vivo pharmacology testing.
End-to-end solutions for antibody programs and applications.
Funding Insights of Distributed Bio
- Total Funding Total Funding
- Total Rounds 1
- Last Round Grant — $197,339
-
First Round
First Round
(14 Aug 2019)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2019 | Amount | Grant - Distributed Bio | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Distributed Bio
Distributed Bio has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Charles River Laboratories and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Provider of drug discovery and preclinical development services
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Distributed Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Distributed Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Distributed Bio Comparisons
Competitors of Distributed Bio
Distributed Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
|
| domain | founded_year | HQ Location |
Dental implants and regenerative dentistry products are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Distributed Bio
Frequently Asked Questions about Distributed Bio
When was Distributed Bio founded?
Distributed Bio was founded in 2010 and raised its 1st funding round 9 years after it was founded.
Where is Distributed Bio located?
Distributed Bio is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Who is the current CEO of Distributed Bio?
Jacob Glanville is the current CEO of Distributed Bio. They have also founded this company.
How many employees does Distributed Bio have?
As of Dec 31, 2022, the latest employee count at Distributed Bio is 26.
What does Distributed Bio do?
Distributed bio Inc has computational immunology platform, called Abgenesis for mining of antibodies, peptides, and TCRs, using this technology they have produced their own SuperHuman Library of Antibodies. Along with this, they have a discovery platform and an epitope focusing vaccine technology to elicit immune responses against specific surfaces, Additionally, they offer Bioengineering services, antibody informatics, including sequence and structural analysis, affinity maturation and humanization, NextGen repertoire sequencing, phage display panning library analysis, and repertoire biomarker analysis.
Who are the top competitors of Distributed Bio?
Distributed Bio's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does Distributed Bio offer?
Distributed Bio offers Antibody Phage Display Services, SuperHuman and Cosmic scFV Libraries, Tungsten VHH Libraries, Tumbler Antibody Optimization Platform, and 2 more products and services.
Who are Distributed Bio's investors?
Distributed Bio has 2 investors. Key investors include Charles River Laboratories, and HHS.